FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121523819> ?p ?o ?g. }

• W2121523819 endingPage "1016" @default.
• W2121523819 startingPage "1016" @default.
• W2121523819 abstract "Postpericardiotomy syndrome, postoperative atrial fibrillation (AF), and postoperative effusions may be responsible for increased morbidity and health care costs after cardiac surgery. Postoperative use of colchicine prevented these complications in a single trial.To determine the efficacy and safety of perioperative use of oral colchicine in reducing postpericardiotomy syndrome, postoperative AF, and postoperative pericardial or pleural effusions.Investigator-initiated, double-blind, placebo-controlled, randomized clinical trial among 360 consecutive candidates for cardiac surgery enrolled in 11 Italian centers between March 2012 and March 2014. At enrollment, mean age of the trial participants was 67.5 years (SD, 10.6 years), 69% were men, and 36% had planned valvular surgery. Main exclusion criteria were absence of sinus rhythm at enrollment, cardiac transplantation, and contraindications to colchicine.Patients were randomized to receive placebo (n=180) or colchicine (0.5 mg twice daily in patients ≥70 kg or 0.5 mg once daily in patients <70 kg; n=180) starting between 48 and 72 hours before surgery and continued for 1 month after surgery.Occurrence of postpericardiotomy syndrome within 3 months; main secondary study end points were postoperative AF and pericardial or pleural effusion.The primary end point of postpericardiotomy syndrome occurred in 35 patients (19.4%) assigned to colchicine and in 53 (29.4%) assigned to placebo (absolute difference, 10.0%; 95% CI, 1.1%-18.7%; number needed to treat = 10). There were no significant differences between the colchicine and placebo groups for the secondary end points of postoperative AF (colchicine, 61 patients [33.9%]; placebo, 75 patients [41.7%]; absolute difference, 7.8%; 95% CI, -2.2% to 17.6%) or postoperative pericardial/pleural effusion (colchicine, 103 patients [57.2%]; placebo, 106 patients [58.9%]; absolute difference, 1.7%; 95% CI, -8.5% to 11.7%), although there was a reduction in postoperative AF in the prespecified on-treatment analysis (placebo, 61/148 patients [41.2%]; colchicine, 38/141 patients [27.0%]; absolute difference, 14.2%; 95% CI, 3.3%-24.7%). Adverse events occurred in 21 patients (11.7%) in the placebo group vs 36 (20.0%) in the colchicine group (absolute difference, 8.3%; 95% CI; 0.76%-15.9%; number needed to harm = 12), but discontinuation rates were similar. No serious adverse events were observed.Among patients undergoing cardiac surgery, perioperative use of colchicine compared with placebo reduced the incidence of postpericardiotomy syndrome but not of postoperative AF or postoperative pericardial/pleural effusion. The increased risk of gastrointestinal adverse effects reduced the potential benefits of colchicine in this setting.clinicaltrials.gov Identifier: NCT01552187." @default.
• W2121523819 created "2016-06-24" @default.
• W2121523819 creator A5005951239 @default.
• W2121523819 creator A5007633242 @default.
• W2121523819 creator A5009705188 @default.
• W2121523819 creator A5010051308 @default.
• W2121523819 creator A5019329471 @default.
• W2121523819 creator A5020030473 @default.
• W2121523819 creator A5021159805 @default.
• W2121523819 creator A5028805159 @default.
• W2121523819 creator A5029989975 @default.
• W2121523819 creator A5029990542 @default.
• W2121523819 creator A5031872274 @default.
• W2121523819 creator A5039819023 @default.
• W2121523819 creator A5042021806 @default.
• W2121523819 creator A5042710208 @default.
• W2121523819 creator A5050782259 @default.
• W2121523819 creator A5051972004 @default.
• W2121523819 creator A5053002045 @default.
• W2121523819 creator A5055760440 @default.
• W2121523819 creator A5057465772 @default.
• W2121523819 creator A5057588405 @default.
• W2121523819 creator A5059872431 @default.
• W2121523819 creator A5062701625 @default.
• W2121523819 creator A5064606876 @default.
• W2121523819 creator A5067030113 @default.
• W2121523819 creator A5067245493 @default.
• W2121523819 creator A5069694231 @default.
• W2121523819 creator A5077328297 @default.
• W2121523819 creator A5082351962 @default.
• W2121523819 creator A5082607964 @default.
• W2121523819 creator A5084420828 @default.
• W2121523819 creator A5087893758 @default.
• W2121523819 creator A5015038363 @default.
• W2121523819 date "2014-09-10" @default.
• W2121523819 modified "2023-10-03" @default.
• W2121523819 title "Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation" @default.
• W2121523819 cites W118135303 @default.
• W2121523819 cites W1977115602 @default.
• W2121523819 cites W1994401913 @default.
• W2121523819 cites W2029901652 @default.
• W2121523819 cites W2037048529 @default.
• W2121523819 cites W2038093356 @default.
• W2121523819 cites W2038504749 @default.
• W2121523819 cites W2043196772 @default.
• W2121523819 cites W2059812555 @default.
• W2121523819 cites W2064027325 @default.
• W2121523819 cites W2068325306 @default.
• W2121523819 cites W2074375637 @default.
• W2121523819 cites W21006809 @default.
• W2121523819 cites W2111615532 @default.
• W2121523819 cites W2113317055 @default.
• W2121523819 cites W2118556143 @default.
• W2121523819 cites W2123500915 @default.
• W2121523819 cites W2126487848 @default.
• W2121523819 cites W2129554354 @default.
• W2121523819 cites W2133289609 @default.
• W2121523819 cites W2144425741 @default.
• W2121523819 cites W2151995209 @default.
• W2121523819 cites W2157786086 @default.
• W2121523819 cites W2169192416 @default.
• W2121523819 doi "https://doi.org/10.1001/jama.2014.11026" @default.
• W2121523819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25172965" @default.
• W2121523819 hasPublicationYear "2014" @default.
• W2121523819 type Work @default.
• W2121523819 sameAs 2121523819 @default.
• W2121523819 citedByCount "253" @default.
• W2121523819 countsByYear W21215238192014 @default.
• W2121523819 countsByYear W21215238192015 @default.
• W2121523819 countsByYear W21215238192016 @default.
• W2121523819 countsByYear W21215238192017 @default.
• W2121523819 countsByYear W21215238192018 @default.
• W2121523819 countsByYear W21215238192019 @default.
• W2121523819 countsByYear W21215238192020 @default.
• W2121523819 countsByYear W21215238192021 @default.
• W2121523819 countsByYear W21215238192022 @default.
• W2121523819 countsByYear W21215238192023 @default.
• W2121523819 crossrefType "journal-article" @default.
• W2121523819 hasAuthorship W2121523819A5005951239 @default.
• W2121523819 hasAuthorship W2121523819A5007633242 @default.
• W2121523819 hasAuthorship W2121523819A5009705188 @default.
• W2121523819 hasAuthorship W2121523819A5010051308 @default.
• W2121523819 hasAuthorship W2121523819A5015038363 @default.
• W2121523819 hasAuthorship W2121523819A5019329471 @default.
• W2121523819 hasAuthorship W2121523819A5020030473 @default.
• W2121523819 hasAuthorship W2121523819A5021159805 @default.
• W2121523819 hasAuthorship W2121523819A5028805159 @default.
• W2121523819 hasAuthorship W2121523819A5029989975 @default.
• W2121523819 hasAuthorship W2121523819A5029990542 @default.
• W2121523819 hasAuthorship W2121523819A5031872274 @default.
• W2121523819 hasAuthorship W2121523819A5039819023 @default.
• W2121523819 hasAuthorship W2121523819A5042021806 @default.
• W2121523819 hasAuthorship W2121523819A5042710208 @default.
• W2121523819 hasAuthorship W2121523819A5050782259 @default.
• W2121523819 hasAuthorship W2121523819A5051972004 @default.
• W2121523819 hasAuthorship W2121523819A5053002045 @default.
• W2121523819 hasAuthorship W2121523819A5055760440 @default.
• W2121523819 hasAuthorship W2121523819A5057465772 @default.

• next